Clinical study on Feiyanning Granule in treating intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome
|更新时间:2022-07-13
|
Clinical study on Feiyanning Granule in treating intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome
Shanghai Journal of Traditional Chinese MedicineVol. 56, Issue 6, Pages: 42-45(2022)
ZHENG Zhan,XU Zhenye,LU Qijun,et al.Clinical study on Feiyanning Granule in treating intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(06):42-45.
ZHENG Zhan,XU Zhenye,LU Qijun,et al.Clinical study on Feiyanning Granule in treating intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome[J].Shanghai Journal of Traditional Chinese Medicine,2022,56(06):42-45. DOI: 10.16305/j.1007-1334.2022.2110076.
Clinical study on Feiyanning Granule in treating intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome
Objective,2,To observe the clinical efficacy of Feiyanning Granule in treating the intermediate and advanced stage lung squamous cell carcinoma (LSCC) of male patients with essence and qi deficiency syndrome.,Methods,2,Sixty male patients with intermediate and advanced stage LSCC of essence and qi deficiency syndrome were randomly divided into a treatment group (,n,=30) and a control group (,n,=30). The treatment group was treated with Feiyanning Granule, while the control group was treated with Feiyanning Granule simulant. The course of treatment of both groups lasted 2 months. We observed the clinical efficacy, and compared the changes of Traditional Chinese Medicine (TCM) syndrome score, Karnofsky Performance Status (KPS) score, serum tumor markers and related immune indexes.,Results,2,①After treatment, the disease control rate of the treatment group was 80.0% and that of the control group was 56.7%. The clinical efficacy of the treatment group was better than that of the control group (,P,<,0.05). ②According to the intra-group comparison before and after treatment, the scores of fatigue, cough, hemoptysis, pain and insomnia in the treatment group decreased (,P,<,0.05), while there was no significant difference in the above-mentioned TCM syndrome scores in the control group (,P,>,0.05). After treatment, the scores of fatigue, cough, hemoptysis, pain and insomnia in the treatment group were lower than those in the control group (,P,<,0.05). ③The KPS score of the treatment group was better than that of the control group (,P,<,0.05). ④The intra-group comparison before and after treatment showed that the levels of cancer antigen 12-5 (CA12-5), cytokeratin 19 fragment antigen 21-1 (CYFRA21-1) and squamous cell cancinoma associated antigen(SCC) in the treatment group decreased (,P,<,0.05); there was no significant difference in the level of tumor markers in the control group (,P,>,0.05); after treatment, the levels of CA125, CYFRA21-1 and SCC in the treatment group were lower than those in the control group (,P,<,0.05). ⑤There was no significant difference in the immune indexes between the two groups before and after treatment (,P,>,0.05); After treatment, the levels of CD4, +, and NK cells in the treatment group were higher than those in the control group (,P,<,0.05).,Conclusion,2,Feiyanning Granule is effective in the treatment of intermediate and advanced stage lung squamous cell carcinoma of male patients with essence and qi deficiency syndrome, as it can effectively improve the clinical symptoms and immune function, enhance the quality of life, reduce serum levels of tumor markers and inhibit tumor growth.
关键词
肺鳞癌中晚期肿瘤精气两亏证肺岩宁临床试验
Keywords
lung squamous cell carcinomaintermediate and advanced tumoressence and qi deficiency syndromeFeiyanningclinical trial
references
SIEGEL R L, MILLER K D, JEMAL A. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33.
CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
KOBAYASHI-WATANABE N, SATO A, WATANABE T, et al. Functional analysis of Discoidin domain receptor2 mutation and expression in squamous cell lung cancer[J/OL]. Lung Cancer, 2017, 110: 35-41[2021-09-30]. https://pubmed.ncbi.nlm.nih.gov/28676216/https://pubmed.ncbi.nlm.nih.gov/28676216/.
SCHULER M, YANG J C, PARK K, et al. Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase Ⅲ randomized LUX-Lung 5 trial[J]. Ann Oncol, 2016, 27(3): 417-423.
HU W, LIU Y, CHEN J. Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer[J]. Oncotarget, 2017, 8(15): 25046-25054.
XU Z Y, JIN C J, ZHOU C C, et al. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy[J]. J Cancer Res Clin Oncol, 2011, 137(7): 1117-1122.
THERASSE P, ARBUCK S G, EISENHAUER E A, et al. New guidelines to evaluate the response to treatment in solid tumors[J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
Effect of wearable ankle point stimulator combined with comprehensive rehabilitation training on foot and ankle function in children with spastic hemiplegic cerebral palsy
Clinical study on treatment of severe non‑proliferative diabetic retinopathy with modified Taohong Siwu Decoction and laser therapy
Clinical study on the treatment of lower limb venous ulcer of qi deficiency and blood stasis syndrome with Modified Qilong Quyu Mixture plus external treatment and conditioning
Clinical observation on Sanleng Xiaoliu Mixture combined with chemotherapy in treatment of advanced gastric cancer of intermingled phlegm and stasis syndrome
Observation on regulating effect of spirit⁃regulating acupuncture on female overactive bladder and accompanying emotional abnormality
Related Author
No data
Related Institution
Yangzhi Rehabilitation Hospital, Tongji University
Shanghai University of Traditional Chinese Medicine
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine